Opthea Limited (OPT)
NASDAQ: OPT · Real-Time Price · USD
3.410
+0.050 (1.49%)
Mar 17, 2025, 4:00 PM EDT - Market closed
Opthea Revenue
Opthea had revenue of $149.00K in the half year ending December 30, 2024, a decrease of -24.39%. This brings the company's revenue in the last twelve months to $208.86K, down -46.47% year-over-year. In the fiscal year ending June 30, 2024, Opthea had annual revenue of $261.86K, down -32.03%.
Revenue (ttm)
$208.86K
Revenue Growth
-46.47%
P/S Ratio
2,233.91
Revenue / Employee
$6,329
Employees
33
Market Cap
466.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 261.86K | -123.42K | -32.03% |
| Jun 30, 2023 | 385.28K | 186.27K | 93.60% |
| Jun 30, 2022 | 199.01K | 103.44K | 108.24% |
| Jun 30, 2021 | 95.56K | -5.13K | -5.09% |
| Jun 30, 2020 | 100.69K | -136.12K | -57.48% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
OPT News
- 6 days ago - Opthea Announces COAST Phase 3 Trial Topline Results - GlobeNewsWire
- 27 days ago - Opthea Announces Phase 2b Wet AMD Publication - GlobeNewsWire
- 7 weeks ago - Opthea to Present at Oppenheimer Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Opthea Wet AMD Data Featured at Macula Society Meeting - GlobeNewsWire
- 2 months ago - Opthea to Host Investor Days in New York and Australia - GlobeNewsWire
- 3 months ago - Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Opthea's Wet AMD Program to be Featured at FLORetina 2024 - GlobeNewsWire
- 4 months ago - Opthea Appoints Kathy Connell to Board of Directors - GlobeNewsWire